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Objective   This study aimed to investigate a prospective association between shift work and use of psychotropic 
medicine.
Methods   Survey data from random samples of the general working population of Denmark (N=19 259) were 
linked to data from national registers. Poisson regression was used for analyses of prospective associations 
between shift work and redeemed prescriptions of psychotropic medicine. Prevalent cases were excluded at 
baseline. In secondary analyses, we tested differential effects on subsets of psychotropic medicine and, cross-
sectionally, we studied correspondence between estimates based on psychotropic medicine and self-reported 
mental health. According to the protocol we interpret results from the secondary analyses following the principles 
for nested hypothesis testing, if the primary analyses reject the null-hypothesis, and otherwise we regard it as 
hypothesis generating exploratory analyses.
Results   In the primary analysis, the rate ratio for incidence of psychotropic medicine among shift workers was 1.09 
(95% confidence interval 0.99–1.21). Results from the secondary analyses suggested increased incidence of use 
of hypnotics, sedatives and antidepressants and decreased incidence of use of anxiolytics. Cross-sectional analysis 
suggested increased risk for use of psychotropic medicine (all kinds), but not for poor self-rated mental health.
Conclusions   Results did not support that working in shifts to the extent that is currently practiced in Denmark is 
associated with an increased incidence of overall psychotropic medicine use. Future studies should test, whether 
there is a differential incidence for different drugs among shift workers as suggested by the secondary analyses 
and how psychotropic medicine use and mental health are related.
Key terms   antidepressant; anxiolytic; mental health; prescription drug; occupational health; sedative; shift worker.
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Shift work is related to disturbances in the circadian 
rhythm and sleep disturbances, which are suspected to 
contribute to mental health problems (1–4). A meta-
analysis of 11 primary studies concluded that night shift 
work was significantly associated with an increased risk 
of depression (5), and a prospective study found a ‘flex-
ible/non-regulated’ schedule prospectively associated 
with antidepressant prescription among females (6). 
Other prospective studies have not found shift work 
associated with the development of mental health prob-
lems (7, 8) nor with use of psychotropic drugs (9–11). 
Thus, it is essential to investigate the possible negative 
effects of shift work on mental health.
There may be different mechanisms behind a pos-
sible association between shift work and mental health. 
Circadian misalignment may disrupt the internal syn-
chronization of the hypothalamic-pituitary-adrenal 
(HPA) axis, that is responsible for several neurotrans-
mitters and hormones (1). In turn this may lead to 
abnormal responses to stress. And together with sleep 
disturbances, the stress responses may affect mood, and 
vigilance (12), and as such the regulation of emotions 
(1). Shiftwork is furthermore known to have negative 
impact on work-life balance, social life issues (13, 
14) and on marital satisfaction (15). And beside this, 
some of the occupational sectors where shift work is 
prevalent, eg, healthcare and protective services, are 
also sectors chracterized by increased risk for exposure 
to traumatic events (16, 17). Thus, biological as well as 
social and environmental factors may interact as under-
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lying mechanisms behind an association between shift 
work and mental health.
The aim of the present study was to assess if shift 
work is associated with increased risk of psychotropic 
medicine use. Firstly, we investigated the prospective 
association between shift work and incident use of 
psychotropic medicine. Secondly, we tested differential 
prospective effects on subsets of psychotropic medicine. 
Thirdly, in order to evaluate whether prescription bias 
was present, we related the association between shift 
work and self-rated mental ill health and medicine use, 
respectively.
Methods
The data material, the hypotheses and the statistical 
methods of the study were defined, peer-reviewed and 
published in a detailed study protocol (18), before we 
performed the linkage between the exposure and the 
outcome data of the study. For information about the 
data material and statistical methods and models see 
Hannerz & Albertsen (18, 19). Only a brief description 
of the data and methods will be given here.
Data material
The data material was obtained through a linkage of 
survey data from the Copenhagen Psychosocial Ques-
tionnaire study (COPSOQ) sample of 2004, the Danish 
National Working Environment Survey (DANES) of 
2008, and the Danish Work Environment Cohort Study 
(DWECS) of 1995, 2000, 2005, and 2010 with data from 
the Central Person Register, the Employment Classifica-
tion Module, and the Danish National Prescription Reg-
istry (DNPR). The COPSOQ study sample is a random 
sample, which comprises 4732 people, 20–59 years of 
age, whereof 3517 are wage earners (20). DANES is 
based on a random sample of the Danish population in 
2008. It comprises responses from 6531 persons 18–59 
years of age, of which 4919 are employees. The DWECS 
is an open cohort study, based on a random sample of 
people 18–59 year of age in the Danish population. The 
cohort contains a representative cross-sectional data-
collection among at least 5000 employees every fifth 
year from 1990–2010 (21).
Primary analysis
Case definition. A person was defined as a case if and 
when he or she redeemed a prescription for drugs in the 
anatomical therapeutic chemical (ATC) code category 
N05 [psycholeptica=antipsychotics (N=58), anxiolyt-
ics (N=495), hypnotics and sedatives (N=752)] or N06 
[psychoanaleptica=antidepressants (N=941), psycho-
stimulants (N=12) and anti-dementia drugs (N=0)]. In 
addition, 656 cases received combinations of different 
drugs. In total there were 2914 cases. For specification 
of this see (19).
Follow-up and inclusion criteria. Each of the included samples 
was followed for a period of 2–5 years (depending on the 
time available between the sampling and the end of the 
study period, 31 December 2012) beginning at the start of 
the calendar year succeeding the one in which they were 
sampled. Participants who redeemed a prescription for 
a medication with an ATC-code that belong to the case 
definition, during the calendar year preceding baseline 
(prevalent cases) were excluded from the follow-up. 
Participants could participate in several rounds. A partici-
pant who reached the clinical endpoint of the study was 
not allowed to re-enter the follow-up, ie, there would be 
maximum one case per person. People aged 21–59 years 
at the start of the follow-up period and employed ≥32 
weekly working hours around the time of the interview 
were included [for further information see (18)].
Exposure assessment. The surveys contain information 
on the participants’ normal work schedules. The ques-
tions and response categories vary slightly between the 
questionnaires, but all of them can identify workers who 
are either on fixed night shifts or rotational shift work 
schedules (see supplementary material, www.sjweh.fi/
show_abstract.php?abstract_id=3872, appendix 1 and 2).
Statistical model. Poisson regression was used to model 
incidence rates of redeemed prescriptions for psychotro-
pic medicine as a function of currently working in shifts 
(permanent night shifts, rotational shift work schedules 
(both with and without night shifts) or irregularly placed 
hours versus permanent day, morning or evening). The 
analysis was adjusted for sex, age (10-year classes), 
sample (DWECS 1995; DWECS 2000; COPSOQ 2004; 
DWECS 2005; DANES 2008; DWECS 2010), weekly 
working hours (32–40, 41–48, >48 hours/week) and 
socioeconomic status. The logarithm of person years at 
risk was used as offset. The significance level was set 
to 0.05. A likelihood ratio test was used to test the null 
hypothesis.
Secondary analyses
As described in the protocol (18), we performed a series 
of secondary analyses (for results from all analyses see 
appendix 3). Sensitivity analyses were performed in the 
same way as we did in the primary analysis, but with 
endpoints defined by the subsets of N05B (anxiolytics), 
N05C (hypnotics and sedatives), and N06A (antidepres-
sants). In order to evaluate whether prescription bias 
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was present, we compared the association between shift 
work and self-rated mental ill health (MHI-5; cut-off: 
52 points) with the association between shift work and 
redeemed prescriptions. Logistic regression was used to 
model the odds of outcomes in cross-sectional analyses. 
The analyses were adjusted like in the primary analysis. 
In the protocol (18) it was described that interpretation 
of results from the secondary analyses would follow the 
principles for nested hypothesis testing, if the primary 
analyses rejected the null-hypothesis and otherwise, they 
would be regarded as hypothesis generating exploratory 
analyses. 
Results
In the primary analysis, the inclusion criteria for age, 
employment status and working hours were fulfilled for 
29 837 observations. Of these, we excluded 3084 due 
to prior redeemed case prescriptions, and 794 due to 
missing data on shift work, which left us with 25 959 
observations (19 259 persons) to be included in the 
analysis. The included observations yielded a total of 
2914 new cases of psychotropic drug use in 99 019 
person years at risk. For details of each of the included 
data sets see (19).
In the prospective analysis, we found no overall 
increased risk for incidence of psychotropic drug use 
among shift workers compared to fixed day workers 
(P=0.09). Thus, the likelihood ratio test did not reject the 
null hypothesis. The estimated rate ratio, person years at 
risk and number of cases are given in table 1.
In the sensitivity analysis (see table 2), we observed 
higher incidence for hypnotics and sedatives and antide-
pressants, and lower incidence for anxiolytics.
The cross-sectional analysis showed that working 
in shifts was associated with an increased propensity 
to redeem prescriptions for psychotropic drugs, but not 
with an increased tendency to report poor mental health 
(see table 3).
Discussion
In the primary analysis, we did not find a statistically 
significant association between shift work and the inci-
dence of psychotropic drug usage (all types combined) 
among Danish employees. Given that this study had 
enough power to detect an effect, the primary results 
support a conclusion saying that working in shifts to 
the extent that is currently practiced in Denmark is 
not associated with an increased incidence of overall 
psychotropic medicine use. The overall result is in line 
with findings from other prospective studies that did 
not find work in shift associated with development of 
mental health problems (7, 8) or with use of psycho-
tropics (9–11). As mentioned in the introduction, some 
previous prospective studies have found associations 
between shift work and psychotropic drug usage. How-
ever, one of these studies (6) was based on analyses 
with rather low statistical power and multiple tests, of 
which only one reached significance. The other (5) only 
included two prospective studies in a meta-analysis – 
one of which was severely underpowered and the other 
reported in an untransparent way without inclusion of 
the prospective findings. The authors recommend stud-
ies with stronger designs in order to draw confirmative 
relationships.
It is important to notice that results from this study 
do not address whether working in shifts for some people 
may be contraindicated due to the experience of mental 
health problems (eg, serious sleeping problems). In line 
with the findings of this study, results from a large non-
randomized pseudo-trial from Finland (22) showed no 
increased risk of developing common mental disorder 
after changing from non-night to night work. The authors 
Table 3. The estimated odds ratios (OR) of the outcomes as a function 
of shift versus non-shift work. [CI=confidence interval]
Case definition Shift 
work
Observations Cases OR a 95% CI
Use of psychotropic  
medication (P=0.0058)
Yes 2561 217 1.26 1.08–1.48
No 16 172 1178 1.00
Poor self-rated mental 
health (P=0.6849)
Yes 2507 109 1.03 0.87–1.22
No 15 842 679 1.00
a The analyses were controlled for sex, age, socioeconomic status, working 
hours, and sample.
Table 1. The estimated prospective rate ratio (RR) for incident use of 
any type psychotropic drugs [CI=confidence interval; Pyrs=person 
years of risk].
Population Shift work Pyrs Cases RR a 95% CI
All employees Yes 13 812 440 1.09 0.99–1.21
No 85 207 2474 1.00
a The analysis was controlled for sex, age, socioeconomic status, working 
hours, and sample.
Table 2. Rate ratio (RR) with 95% confidence interval (CI) for incident use 
of anxiolytics, hypnotics and sedatives, and antidepressants, as a func-





Cases RR a 95% CI
N05B anxiolytics Yes 15 653 141 0.86 0.72–1.02
No 95 039 973 1.00
N05C hypnotics and sedatives Yes 15 481 230 1.21 1.05–1.40
No 94 348 1188 1.00
N06A antidepressants Yes 15 132 281 1.23 1.08–1.40
No 93 308 1415 1.00
a Adjusted for sex, age, socioeconomic status, weekly working hours and sample.
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found, however, (i) increased likelihood of recovery 
from common mental disorder if night workers changed 
from night- to non-night work and that (ii) night workers 
were more likely to change to non-night work if they had 
developed common mental disorder. Thus, the selection 
out of night work may be dependent on the individuals’ 
experience of mental health problems (including sleeping 
disorders). Thus, employees whose mental well-being is 
affected are likely to change their schedules to day work, 
and this change is – in turn – likely to help them recover 
from the common mental disorder.
Results from the secondary analyses suggested 
increased incidence for the use of hypnotics, sedatives, 
and antidepressants and decreased incidence for the use 
of anxiolytics among shift workers. A simple interpreta-
tion of the differential effects may be that it was a coin-
cidence. Another interpretation could be that shift work 
increases the incidence of sleeping problems and depres-
sion and decreases the incidence of anxiety. These oppo-
sitely directed effects cancel out each other and give a 
non-significant total effect. If this interpretation is right, 
different incidences of diagnoses among shift workers 
versus others should be hypothesized. Both interpreta-
tions should be tested in future studies by including both 
several psychotropic drugs and diagnoses as outcomes. 
A third interpretation could be that there are different 
practices for prescription of psychotropics to people 
working in shifts compared to non-shift workers. The 
general practitioner may decide the specific medication 
for mental health and sleeping problems among people 
working in shifts taking into consideration the require-
ment of often being awake and not being too tired at 
night and being able to sleep during the day. As one of 
the side-effects of anxiolytics may be drowsiness, it is 
likely that the general practitioner will rather prescribe 
antidepressants over anxiolytics to people working in 
shifts and suffering from anxiety. This interpretation 
will get support if studies find no difference in diagnoses 
of depression and anxiety among shift workers versus 
non-shift workers. Results from a survey on the use of 
psychotropic medication in the general populations of 
France, Germany, Italy, and the United Kingdom lend 
support to this interpretation: "Subjects said that they 
were taking an antidepressant to reduce depression in 
30.7% of cases; 25.5% said it was to help them to sleep; 
in 24.5% it was to reduce anxiety; and in 13.4% it was 
to help them to sleep and to reduce anxiety and depres-
sion" (23). Thus, the prescription of psychotropics is not 
always specific for specific sufferings.
Cross-sectional results suggested increased preva-
lence of psychotropic drug use but not poor mental 
health among shift workers. These results may reflect 
that the medication has had a positive effect on the 
perception of mental health. Therefore, we cannot be 
sure whether the increased prevalence of drug use was 
due to an increased need of treatment for mental health 
problems or an increased propensity to seek treatment 
(eg, for sleeping problems). We can only conclude that 
the two outcomes give different estimates of risk. As 
suggested above, future studies may also shed more light 
on possible prescription bias. Clarifying the relation 
between shift work and changes in mental health and 
drug use would probably require frequent follow-up on 
both outcomes or more clinical studies.
Strengths and weaknesses
Within-study selection bias was eliminated through 
our study protocol, in which hypotheses and statistical 
models were specified, peer reviewed, and published 
before the questionnaire data were linked to the reg-
isters. The study population was randomly sampled 
from the target population and the statistical power 
was sufficiently large to detect important effects. The 
problem with reversed causality was minimized through 
the prospective design and the exclusion of prevalent 
cases. Bias from incomplete follow-up data was elimi-
nated by use of a clinical endpoint that was ascertained 
through national registers, which cover all residents 
of the target population. As suggested by results from 
previous research, selection processes into (24) as well 
as out of shift work (22) are likely, and perception of 
mental health and sleep quality may play a role in both 
selection processes. A limitation of the study was that 
it included neither measures of the length of exposure 
or previous daytime work among the shift workers nor 
previous shift work among the non-shift workers. Due 
to this limitation, the results cannot rule out a potential 
dose–response effect of shift work on mental health. For 
further methodological considerations see (19).
Concluding remarks
Results did not support that working in shifts – to the 
extent that is currently practiced in Denmark – is associ-
ated with an increased incidence of overall psychotropic 
medicine use. Future studies should test whether there is 
a differential incidence for different drugs among shift 
workers as suggested by the secondary analyses and if 
there is prescription bias for the outcome of psychotro-
pic medicine.
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